(Q44025566)

29 November 2017

Risk of lymphoma and leukaemia after bacille Calmette-Guérin and smallpox vaccination: a Danish case-cohort study (English)

1 reference

29 November 2017

1 reference

1 reference

0 references

9

1 reference

29 November 2017

Marie Villumsen

1

0 references

Signe Sørup

Signe Sørup

2

0 references

Jennifer L. Baker

Jennifer L Baker

6

0 references

Thorkild I.A. Sørensen

8

Thorkild I A Sørensen

1 reference

29 November 2017

Christine Stabell Benn

7

Christine Stabell Benn

1 reference

29 November 2017

4

Henrik Ravn

1 reference

29 November 2017

Tine Jess

3

1 reference

29 November 2017

Thomas Relander

5

1 reference

29 November 2017

Adam Roth

10

1 reference

29 November 2017

language of work or name

English

0 references

publication date

9 September 2009

1 reference

29 November 2017

1 reference

29 November 2017

27

1 reference

29 November 2017

6950-6958

1 reference

29 November 2017

49

1 reference

Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: Observations from vaccination trials in Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Community cohort study of rotavirus and other enteropathogens: are routine vaccinations associated with sex-differential incidence rates?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diphtheria-tetanus-pertussis vaccinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Is susceptibility to severe infection in low-income countries inherited or acquired?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Bacillus Calmette-Guérin vaccination and infant mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Potential health effects from non-specific stimulation of the immune function in early age: the example of BCG vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Smallpox vaccination and risk of allergy and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Aetiology of acute leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Epidemiology and etiology of non-Hodgkin lymphoma--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Infection and pediatric acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

The epidemiology of non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Infectious agents as causes of non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

An infectious aetiology for childhood acute leukaemia: a review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Altered immunity as a risk factor for non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

A case-control study of non-T cell acute lymphoblastic leukaemia of children in Hokkaido, Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

B.C.G. vaccination and leukemia mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Efficacy of BCG vaccination in prevention of cancer: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Prevention of childhood leukemia by BCG vaccination in newborns? A population-based case-control study in Lower Saxony, Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Leukaemia and B.C.G. A controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Risk indicators in childhood malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

BCG vaccination and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Tuberculin reaction, BCG scar, and lower female mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Cohort profile: the Copenhagen School Health Records Register.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Age at bacille Calmette-Guerin vaccination and risk of allergy and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Birth weight and childhood leukemia: a meta-analysis and review of the current evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

A case-cohort design for epidemiologic cohort studies and disease prevention trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Computing the Cox model for case cohort designs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Analysis of case-cohort designs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Multiple vaccinations, health, and recall bias within UK armed forces deployed to Iraq: cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Comparison of case-cohort estimators based on data on premature death of adult adoptees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Heterologous immunity and the nonspecific effects of vaccines: a major medical advance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

The immunobiology of cancer immunosurveillance and immunoediting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.103

10.1016/J.VACCINE.2009.08.103

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference